留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

实体器官移植受者的免疫功能测定研究进展

吕海金 易慧敏

吕海金, 易慧敏. 实体器官移植受者的免疫功能测定研究进展[J]. 器官移植, 2014, 5(4): 257-260. doi: 10.3969/j.issn.1674-7445.2014.04.014
引用本文: 吕海金, 易慧敏. 实体器官移植受者的免疫功能测定研究进展[J]. 器官移植, 2014, 5(4): 257-260. doi: 10.3969/j.issn.1674-7445.2014.04.014

实体器官移植受者的免疫功能测定研究进展

doi: 10.3969/j.issn.1674-7445.2014.04.014
基金项目: 

国家十二五科技重大专项 2012ZX10002017-005、2012ZX10002-016

国家自然科学基金 U0932006、81172036

详细信息
    通讯作者:

    易慧敏,Email:ylhmin@hotmail.com

  • 中图分类号: R617

  • [1] Wieland E, Olbricht CJ, Süsal C, et al. Bio-markers as a tool for management of immunosuppression in transplant patients[J]. Ther Drug Monit, 2010, 32(5):560-572. doi: 10.1097/FTD.0b013e3181efb3d2
    [2] Barraclough KA, Staatz CE, Isbel NM, et al. Review: pharmacodynamic monitoring of immunosuppression in kidney transplantation[J]. Nephrology, 2010, 15(5):522-532. doi: 10.1111/j.1440-1797.2010.01349.x
    [3] Louis S, Audrain M, Cantarovich D, et al. Long-term cell monitoring of kidney recipients after an antilymphocyte globulin induction with and without steroids[J]. Transplantation,2007, 83(6):712-721. doi: 10.1097/01.tp.0000255683.66156.d3
    [4] 李龙,戚贵生,杨橙,等.全身淋巴照射联合ATG在致敏患者肾移植及逆转AMR中的应用[J].中华器官移植杂志,2013,34(4):209-213.

    Li L, Qi GS, Yang C, et al. Application of combined TLI and low-dose ATG in highly sensitized or AMR renal allograft recipients: clinical practice and mechanism exploration[J]. Chin Organ Transplant,2013,34(4):209-213.
    [5] Ducloux D, Courivaud C, Bamoulid J, et al. Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation[J]. J Am Soc Nephrol,2010,21(5):868-875. doi: 10.1681/ASN.2009090976
    [6] 刘宝阳,张磊,戈海泽,等.大鼠肝移植术后肝脏T淋巴细胞凋亡与免疫耐受的关系[J].器官移植,2012,3(4):213-218. http://www.organtranspl.com/browse/detail/qkid/59/id/611.html

    Liu BY, Zhang L, Ge HY, et al. Relationship between immune tolerance and hepatic T lymphocytes apoptosis after liver transplantation in rats[J]. Organ Transplant, 2012,3(4):213-218. http://www.organtranspl.com/browse/detail/qkid/59/id/611.html
    [7] Jankowski MM, Ignatowska-Jankowska B, Glac W, et al. Cocaine administration increases CD4/CD8 lymphocyte ratio in peripheral blood despite lymphopenia and elevated corticosterone[J]. Int Immunopharmacol,2010,10(10):1229-1234. doi: 10.1016/j.intimp.2010.07.003
    [8] Wahlin BE, Sundstr m C, Holte H, et al. T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab[J]. Clin Cancer Res,2011,17(12):4136-4144. doi: 10.1158/1078-0432.CCR-11-0264
    [9] Li Y, Guo Z, Liu CF, et al. Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+ CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma[J]. Cryobiology,2012,65(1):56-59. doi: 10.1016/j.cryobiol.2012.04.002
    [10] Liu Z, Fan H, Jiang S. CD4(+) T-cell subsets in transplantation[J]. Immunol Rev,2013,252(1):183-191. doi: 10.1111/imr.12038
    [11] Shevach EM. From vanilla to 28 flavors: multiple varieties of T regulatory cells[J]. Immunity,2006,25(2):195-201. doi: 10.1016/j.immuni.2006.08.003
    [12] Sakaguchi S, Ono M, Setoguchi R, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease[J]. Immunol Rev,2006,212:8-27. doi: 10.1111/imr.2006.212.issue-1
    [13] Strioga M, Pasukoniene V, Characiejus D. CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease[J]. Immunology,2011,134(1):17-32. doi: 10.1111/imm.2011.134.issue-1
    [14] Fan H, Cao P, Game DS, et al. Regulatory T cell therapy for the induction of clinical organ transplantation tolerance[J]. Semin Immunol,2011,23(6):453-461. doi: 10.1016/j.smim.2011.08.012
    [15] Baan C, Bouvy A, Vafadari R, et al. Phospho-specific flow cytometry for pharmacodynamic monitoring of immunosuppressive therapy in transplantation[J]. Transplant Res,2012,1(1):20. doi: 10.1186/2047-1440-1-20
    [16] Demmers MW, Baan CC, Janssen M, et al. Substantial proliferation of human renal tubular epithelial cell-reactive CD4+CD28null memory T cells, which is resistant to tacrolimus and everolimus[J]. Transplantation,2014,97(1):47-55. doi: 10.1097/01.TP.0000435697.31148.b2
    [17] Couzi L, Thiébaut R, Carron JC, et al. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients[J]. Transplantation,2008,86(8):1060-1067. doi: 10.1097/TP.0b013e31818758e4
    [18] Zachary AA, Leffell MS. Barriers to successful transplantation of the sensitized patient[J]. Expert Rev Clin Immunol,2010,6(3):449-460. doi: 10.1586/eci.10.14
    [19] Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay[J]. Transplantation,2006,82(5):663-668. doi: 10.1097/01.tp.0000234837.02126.70
    [20] Rodrigo E, López-Hoyos M, Corral M, et al. ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and meta-analysis[J]. Liver Transpl,2012,18(10):1245-1253. http://cn.bing.com/academic/profile?id=2010256207&encoded=0&v=paper_preview&mkt=zh-cn
    [21] Israeli M, Klein T, Sredni B, et al. ImmuKnow: a new parameter in immune monitoring of pediatric liver transplantation recipients[J]. Liver Transpl,2008,14(6):893-898. doi: 10.1002/(ISSN)1527-6473
    [22] Huskey J, Gralla J, Wiseman AC. Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection[J]. Clin J Am Soc Nephrol,2011,6(2):423-429. doi: 10.2215/CJN.04210510
    [23] Torío A, Fernández EJ, Montes-Ares O, et al. Lack of association of immune cell function test with rejection in kidney transplantation[J]. Transplant Proc,2011,43(6):2168-2170. doi: 10.1016/j.transproceed.2011.06.056
    [24] Martinez OM, Villanueva J, Abtahi S, et al. CD30 expression identifies a functional alloreactive human T-lymphocyte subset[J]. Transplantation,1998,65(9):1240-1247. doi: 10.1097/00007890-199805150-00016
    [25] Gaspal FM, Kim MY, McConnell FM, et al. Mice deficient in OX40 and CD30 signals lack memory antibody responses because of deficient CD4 T cell memory[J]. J Immunol,2005,174(7):3891-3896. doi: 10.4049/jimmunol.174.7.3891
    [26] Dai Z, Li Q, Wang Y, et al. CD4+ CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism[J]. J Clin Invest,2004,113(2):310-317. doi: 10.1172/JCI19727
    [27] Chen Y, Tai Q, Hong S, et al. Pretransplantation soluble CD30 level as a predictor of acute rejection in kidney transplantation: a meta-analysis[J]. Transplantation,2012,94(9):911-918. doi: 10.1097/TP.0b013e31826784ad
    [28] Velásquez SY, García LF, Opelz G, et al. Release of soluble CD30 after allogeneic stimulation is mediated by memory T cells and regulated by IFN-γ and IL-2[J]. Transplantation,2013,96(2):154-161. doi: 10.1097/TP.0b013e318296fd69
    [29] Fernández-Ruiz M, López-Medrano F, Varela-Peña P, et al. Monitoring of immunoglobulin levels identifies kidney transplant recipients at high risk of infection[J]. Am J Transplant,2012,12(10):2763-2773. doi: 10.1111/j.1600-6143.2012.04192.x
    [30] Cretel E, Touchard D, Bongrand P, et al. A new method for rapid detection of T lymphocyte decision to proliferate after encountering activating surfaces[J]. J Immunol Methods,2011,364(1/2):33-39.
    [31] Bestard O, Crespo E, Stein M, et al. Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients[J]. Am J Transplant,2013,13(7):1880-1890. doi: 10.1111/ajt.12285
    [32] Sommerer C, Konstandin M, Dengler T, et al. Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies[J]. Transplantation,2006,82(10):1280-1285. doi: 10.1097/01.tp.0000243358.75863.57
    [33] Kalluri HV, Hardinger KL. Current state of renal transplant immunosuppression: Present and future[J]. World J Transplant,2012,2(4):51-68. doi: 10.5500/wjt.v2.i4.51
    [34] Hartmann B, He X, Keller F, et al. Development of a sensitive phospho-p70 S6 kinase ELISA to quantify mTOR proliferation signal inhibition[J]. Ther Drug Monit,2013,35(2):233-239. doi: 10.1097/FTD.0b013e3182804c9b
    [35] Kaltenborn A, Schrem H. Mycophenolate mofetil in liver transplantation: a review[J]. Ann Transplant,2013,18:685-696. doi: 10.12659/AOT.889299
    [36] Glander P, Sombogaard F, Budde K, et al. Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells[J]. Ther Drug Monit,2009,31(3):351-359. doi: 10.1097/FTD.0b013e31819c3f3d
    [37] Fernández-Ruiz M, López-Medrano F, Varela-Peña P, et al. Monitoring of immunoglobulin levels identifies kidney transplant recipients at high risk of infection[J]. Am J Transplant,2012,12(10):2763-2773. doi: 10.1111/j.1600-6143.2012.04192.x
    [38] Li RD, Sun Z, Dong JY, et al. A quantitative assessment model of T-cell immune function for predicting risks of infection and rejection during the early stage after liver transplantation[J]. Clin Transplant,2013,27(5):666-672. http://cn.bing.com/academic/profile?id=2007436860&encoded=0&v=paper_preview&mkt=zh-cn
    [39] Israeli M, Yussim A, Mor E, et al. Preceeding the rejection: in search for a comprehensive post-transplant immune monitoring platform[J]. Transpl Immunol,2007,18(1):7-12. doi: 10.1016/j.trim.2007.03.005
  • 加载中
计量
  • 文章访问数:  42
  • HTML全文浏览量:  50
  • PDF下载量:  10
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-04-10
  • 网络出版日期:  2021-01-19
  • 刊出日期:  2014-07-15

目录

    /

    返回文章
    返回